Tags: Drug.

S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX Inc as a potential male hormonal contraceptive. It binds to the androgen receptor more strongly than older drugs such as andarine with a Ki of 1.7nM and in animal studies it showed both a good ratio of anabolic to androgenic effects and dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment.

S-23.svg
IUPAC name
(2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide
PubChem
24892822

Loading...

This page contains content from the copyrighted Wikipedia article "S-23 (drug)"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.